News from shire plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

02:00 ET

Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted Fast Track designation for...

Jan 23, 2015, 20:25 ET

Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA® (parathyroid hormone)

 Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement today by NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) that the U.S. Food and Drug...

Jan 22, 2015, 02:05 ET

Positive Response From European Decentralised Procedure for Elvanse Adult® ▼ (lisdexamfetamine dimesylate) in Adults With ADHD

- For Release to US Media Only Shire plc (LSE: SHP, NASDAQ: SHPG) today announces the positive response from the European Decentralised Procedure...

Jan 21, 2015, 16:34 ET

Shire Added to Global 100 Sustainability Index

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has for the first time placed in the Global 100 Sustainability Index. Shire was ranked 62nd...

Jan 11, 2015, 11:01 ET

Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

Transaction valued at $5.2 billion Enhances growth profile Shire plc (LSE: SHP, NASDAQ: SHPG) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP)...

Jan 06, 2015, 09:00 ET

Shire to Present at 33rd Annual J.P. Morgan Healthcare Conference

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the 33rd Annual J.P. Morgan...

Dec 10, 2014, 07:00 ET

Shire R&D Day Profiles Innovative Pipeline Expected to Contribute $3 Billion in Product Sales by 2020

Shire plc (LSE: SHP, NASDAQ: SHPG) is hosting a Research and Development (R&D) Day for the investment community focused on the Company's...

Dec 01, 2014, 07:30 ET

Shire to Highlight Pipeline Progress and Breadth of Innovative Portfolio in R&D Day

Company to Profile Key Late-Stage Assets Projected to Drive $3 Billion in Growth by 2020 Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that...

Nov 19, 2014, 09:25 ET

Shire to Relocate Over 500 Jobs to Massachusetts

Establishes Lexington, Mass., as U.S. Operational Headquarters; Decreases Presence in Chesterbrook, Pa.   Interim CFO Appointed  Shire...

Nov 06, 2014, 07:00 ET

Shire to Participate at the Credit Suisse 2014 Global Healthcare Conference

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it will be participating in the Credit Suisse 2014 Healthcare Conference on Wednesday, November...

Oct 24, 2014, 07:00 ET

Shire's Clear and Focused Strategy Delivers Record Quarterly Revenues. Non GAAP Diluted Earnings per ADS up 60%

 - Increases Non GAAP diluted earnings per ADS growth guidance to the high thirty percent range for the full year (2014).  Shire (LSE:...

Oct 20, 2014, 17:22 ET

Shire plc: AbbVie Terminates Offer for Shire

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 20, 2014, 02:00 ET

Interim Chief Financial Officer James Bowling to Step Down

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that James Bowling, Interim Chief Financial Officer (CFO), has notified the Board of Directors of his...

Oct 16, 2014, 04:31 ET

Shire plc: Statement re: AbbVie's Withdrawal of Recommendation

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 15, 2014, 14:32 ET

Shire plc: Statement re: Waiver of Notice of AbbVie's Board Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 15, 2014, 02:13 ET

Shire plc: Statement re: AbbVie's Intention to Reconsider Recommendation

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION...

Oct 09, 2014, 04:30 ET

Shire Provides Regulatory Update on SHP 465, Investigational Compound for ADHD in Adults

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has received further guidance from the U.S. Food and Drug Administration (FDA) on the...

Sep 24, 2014, 16:06 ET

Shire Reaches Final Agreement with U.S. Government

Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached a final agreement with the U.S. Attorney's Offices for the Eastern...

Sep 15, 2014, 08:00 ET

Shire Announces FDA Acceptance for Filing with Priority Review of Supplemental New Drug Application (sNDA) for Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) for Adults with Binge Eating Disorder

Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and Drug Administration (FDA)...

Jul 23, 2014, 07:00 ET

Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen

Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today...